FrostPharma is an entrepreneurial Swedish pharmaceutical company specialized in commercialization

Since the start in 2017, FrostPharma has successfully commercialized a broad range of products across multiple disease areas, covering all Nordic countries and beyond. Key to success is the ability to match specific patient- and health care needs with relevant products in relation to their extensive in-house commercialization competence.